Human TP63(Tumor Protein P63) ELISA Kit
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
RDR-TP63-Mu-48Tests | Reddot Biotech | 48 Tests | 668.4 EUR |
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
RDR-TP63-Mu-96Tests | Reddot Biotech | 96 Tests | 928.8 EUR |
Tumor Protein P63 (TP63) ELISA Kit |
|||
abx595451-96tests | Abbexa | 96 tests | 764.4 EUR |
Tumor Protein P63 (TP63) ELISA Kit |
|||
abx596528-96tests | Abbexa | 96 tests | 867.6 EUR |
Human Tumor Protein P63 (TP63) ELISA Kit |
|||
20-abx153410 | Abbexa |
|
|
Human Tumor Protein p63 (TP63) ELISA Kit |
|||
abx253299-96tests | Abbexa | 96 tests | 801.6 EUR |
Human TP63(Tumor Protein p63) ELISA Kit |
|||
EH3899 | FN Test | 96T | 628.92 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
|||
Human Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5677.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 572.76 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 766.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3090.6 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Tumor Protein P63 (TP63) ELISA Kit |
|||
4-SEC805Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Tumor Protein P63 (TP63) in samples from Tissue homogenates, cell lysates and other biological fluids. with no significant corss-reactivity with analogues from other species. |
|||
Human Tumor Protein P63(TP63)ELISA Kit |
|||
QY-E00160 | Qayee Biotechnology | 96T | 433.2 EUR |
Human Tumor Protein P63 (TP63) Protein |
|||
20-abx655395 | Abbexa |
|
|
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
20-abx154822 | Abbexa |
|
|
Monkey Tumor Protein p63 (TP63) ELISA Kit |
|||
abx358943-96tests | Abbexa | 96 tests | 990 EUR |
Rabbit Tumor Protein p63 (TP63) ELISA Kit |
|||
abx363814-96tests | Abbexa | 96 tests | 990 EUR |
Sheep Tumor Protein p63 (TP63) ELISA Kit |
|||
abx364237-96tests | Abbexa | 96 tests | 1111.2 EUR |
Pig Tumor Protein p63 (TP63) ELISA Kit |
|||
abx360811-96tests | Abbexa | 96 tests | 990 EUR |
Chicken Tumor Protein p63 (TP63) ELISA Kit |
|||
abx355784-96tests | Abbexa | 96 tests | 990 EUR |
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Mu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5834.88 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
|||
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Mu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 585.7 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
|||
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Mu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 785.28 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
|||
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
SEC805Mu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3173.76 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
|||
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|||
4-SEC805Mu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Tumor Protein P63 (TP63) in samples from Tissue homogenates and other biological fluids. with no significant corss-reactivity with analogues from other species. |
|||
Tumor Protein P63 (TP63) Antibody |
|||
20-abx001749 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx124012 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx116376 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx013168 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
abx027712-400ul | Abbexa | 400 ul | 627.6 EUR |
Tumor Protein P63 (TP63) Antibody |
|||
abx027712-80l | Abbexa | 80 µl | 343.2 EUR |
Tumor Protein P63 (TP63) Antibody |
|||
abx025498-100ul | Abbexa | 100 ul | 627.6 EUR |
Tumor Protein P63 (TP63) Antibody |
|||
20-abx178773 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx178774 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx178775 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx330063 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
abx332261-100ul | Abbexa | 100 ul | 510 EUR |
Tumor Protein P63 (TP63) Antibody |
|||
20-abx327716 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx214076 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
20-abx174991 | Abbexa |
|
|
Tumor Protein P63 (TP63) Antibody |
|||
abx238880-100ug | Abbexa | 100 ug | 661.2 EUR |
Tumor Protein P63 (TP63) Antibody |
|||
20-abx214758 | Abbexa |
|
|
ELISA kit for Human TP63 (Tumor Protein P63) |
|||
ELK3138 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Tumor Protein P63 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
ELISA kit for Human TP63 (Tumor Protein p63) |
|||
E-EL-H2304 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Human TP63 (Tumor Protein p63) in samples from Serum, Plasma, Cell supernatant |
|||
Human Tumor Protein p63 (TP63) CLIA Kit |
|||
abx197863-96tests | Abbexa | 96 tests | 990 EUR |
Human Tumor Protein P63 (TP63) CLIA Kit |
|||
20-abx493909 | Abbexa |
|
|
Mouse Tumor Protein P63 (TP63) Protein |
|||
20-abx655396 | Abbexa |
|
|
Mouse Tumor Protein P63 (TP63) Protein |
|||
20-abx655397 | Abbexa |
|
|
Human Tumor Protein P63 (TP63) Protein (OVA) |
|||
20-abx651274 | Abbexa |
|
|
ELISA kit for Mouse TP63 (Tumor Protein P63) |
|||
ELK6941 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Tumor Protein P63 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Mouse Tumor Protein P63 (TP63) CLIA Kit |
|||
20-abx493910 | Abbexa |
|
|
OVA Conjugated Tumor Protein P63 (TP63) |
|||
4-CPC805Hu21 | Cloud-Clone |
|
|
Description: Recombinant Human Tumor Protein P63 expressed in: chemical synthesis |
|||
CLIA kit for Human TP63 (Tumor Protein p63) |
|||
E-CL-H1352 | Elabscience Biotech | 1 plate of 96 wells | 700.8 EUR |
Description: A sandwich CLIA kit for quantitative measurement of Human TP63 (Tumor Protein p63) in samples from Serum, Plasma, Cell supernatant |
|||
Tumor Protein P63 (TP63) Monoclonal Antibody (Human) |
|||
4-MAC805Hu22 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63) |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human) |
|||
4-PAC805Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63) |
|||
Tumor Protein P63 (TP63) Monoclonal Antibody (Human), APC |
|||
4-MAC805Hu22-APC | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC. |
|||
Tumor Protein P63 (TP63) Monoclonal Antibody (Human), Biotinylated |
|||
4-MAC805Hu22-Biotin | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Biotin. |
|||
Tumor Protein P63 (TP63) Monoclonal Antibody (Human), Cy3 |
|||
4-MAC805Hu22-Cy3 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Cy3. |
|||
Tumor Protein P63 (TP63) Monoclonal Antibody (Human), FITC |
|||
4-MAC805Hu22-FITC | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with FITC. |
|||
Tumor Protein P63 (TP63) Monoclonal Antibody (Human), HRP |
|||
4-MAC805Hu22-HRP | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with HRP. |
|||
Tumor Protein P63 (TP63) Monoclonal Antibody (Human), PE |
|||
4-MAC805Hu22-PE | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with PE. |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human), APC |
|||
4-PAC805Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC. |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAC805Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Biotin. |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human), Cy3 |
|||
4-PAC805Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Cy3. |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human), FITC |
|||
4-PAC805Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with FITC. |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human), HRP |
|||
4-PAC805Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with HRP. |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human), PE |
|||
4-PAC805Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with PE. |
|||
Anti-p63/TP63 |
|||
DB-133-0.05 | DB Biotech | 50 μl | 352.8 EUR |
Anti-p63/TP63 |
|||
DB-133-0.1 | DB Biotech | 100 μl | 555.6 EUR |
Tumor Protein P63 Phospho-Ser395 (TP63 pS395) Antibody |
|||
20-abx012715 | Abbexa |
|
|
Tumor Protein P63 Phospho-Ser395 (TP63 pS395) Antibody |
|||
abx333541-100ul | Abbexa | 100 ul | 560.4 EUR |
Tumor Protein P63 Phospho-Ser455 (TP63 pS455) Antibody |
|||
20-abx324486 | Abbexa |
|
|
Tumor Protein P63 Phospho-Ser395 (TP63 pS395) Antibody |
|||
20-abx327760 | Abbexa |
|
|
Tumor Protein P63 (TP63) Monoclonal Antibody (Human), APC-Cy7 |
|||
4-MAC805Hu22-APC-Cy7 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC-Cy7. |
|||
Tumor Protein P63 (TP63) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAC805Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC-Cy7. |
|||
p63 (Tumor Protein p63) |
|||
MO47058 | Neuromics | 100 ul | 418.8 EUR |
Human Tumor Protein P63 ELISA kit |
|||
E01T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Human Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Tumor Protein P63 ELISA kit |
|||
E01T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Human Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Tumor Protein P63 ELISA kit |
|||
E01T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Human Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Anti-p63/TP63 Antibody |
|||
PA2056 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-p63/TP63 Antibody |
|||
PB9152 | BosterBio | 100ug/vial | 400.8 EUR |
Human Tumor protein 63, TP63 ELISA KIT |
|||
ELI-16158h | Lifescience Market | 96 Tests | 988.8 EUR |
Goat Tumor Protein P63 ELISA kit |
|||
E06T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Goat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Tumor Protein P63 ELISA kit |
|||
E06T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Goat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Tumor Protein P63 ELISA kit |
|||
E06T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Goat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Tumor Protein P63 ELISA kit |
|||
E04T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Rabbit Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Tumor Protein P63 ELISA kit |
|||
E04T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Rabbit Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Tumor Protein P63 ELISA kit |
|||
E04T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Rabbit Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Tumor Protein P63 ELISA kit |
|||
E03T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Mouse Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Tumor Protein P63 ELISA kit |
|||
E03T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Mouse Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Tumor Protein P63 ELISA kit |
|||
E03T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Mouse Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Tumor Protein P63 ELISA kit |
|||
E08T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Canine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Tumor Protein P63 ELISA kit |
|||
E08T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Canine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Tumor Protein P63 ELISA kit |
|||
E08T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Canine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Tumor Protein P63 ELISA kit |
|||
E09T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Monkey Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Tumor Protein P63 ELISA kit |
|||
E09T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Monkey Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Tumor Protein P63 ELISA kit |
|||
E09T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Monkey Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Tumor Protein P63 ELISA kit |
|||
E02T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Rat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Tumor Protein P63 ELISA kit |
|||
E02T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Rat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Tumor Protein P63 ELISA kit |
|||
E02T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Rat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Tumor Protein P63 ELISA kit |
|||
E07T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Porcine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Tumor Protein P63 ELISA kit |
|||
E07T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Porcine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Tumor Protein P63 ELISA kit |
|||
E07T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Porcine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Tumor protein 63 (TP63) |
|||
1-CSB-RP116694h | Cusabio |
|
|
Description: Recombinant Human Tumor protein 63(TP63) expressed in E.coli |
|||
ELISA kit for Human Tumor protein 63 (TP63) |
|||
KTE60153-48T | Abbkine | 48T | 398.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Tumor protein 63 (TP63) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Tumor protein 63 (TP63) |
|||
KTE60153-5platesof96wells | Abbkine | 5 plates of 96 wells | 2538 EUR |
Description: Quantitative sandwich ELISA for measuring Human Tumor protein 63 (TP63) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Tumor protein 63 (TP63) |
|||
KTE60153-96T | Abbkine | 96T | 646.8 EUR |
Description: Quantitative sandwich ELISA for measuring Human Tumor protein 63 (TP63) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Mouse Tumor protein 63, Tp63 ELISA KIT |
|||
ELI-12432m | Lifescience Market | 96 Tests | 1038 EUR |
Guinea pig Tumor Protein P63 ELISA kit |
|||
E05T0290-192T | BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Guinea pig Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig Tumor Protein P63 ELISA kit |
|||
E05T0290-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
Description: A competitive ELISA for quantitative measurement of Guinea pig Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig Tumor Protein P63 ELISA kit |
|||
E05T0290-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
Description: A competitive ELISA for quantitative measurement of Guinea pig Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Recombinant Human P63/ TP63 Protein, His, E.coli-100ug |
|||
QP8724-ec-100ug | EnQuireBio | 100ug | 489.6 EUR |
Recombinant Human P63/ TP63 Protein, His, E.coli-10ug |
|||
QP8724-ec-10ug | EnQuireBio | 10ug | 240 EUR |
Recombinant Human P63/ TP63 Protein, His, E.coli-1mg |
|||
QP8724-ec-1mg | EnQuireBio | 1mg | 1958.4 EUR |
Recombinant Human P63/ TP63 Protein, His, E.coli-200ug |
|||
QP8724-ec-200ug | EnQuireBio | 200ug | 760.8 EUR |
Recombinant Human P63/ TP63 Protein, His, E.coli-500ug |
|||
QP8724-ec-500ug | EnQuireBio | 500ug | 1272 EUR |
Recombinant Human P63/ TP63 Protein, His, E.coli-50ug |
|||
QP8724-ec-50ug | EnQuireBio | 50ug | 315.6 EUR |
p63 Antibody / Tumor protein 63 |
|||
R20340-0.1ML | NSJ Bioreagents | 100ul | 409 EUR |
p63 Antibody / Tumor protein 63 |
|||
V3367-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3367-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3367SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3368-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3368-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3368SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3815-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3815-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3815SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3816-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. [UniProt] |
|||
p63 Antibody / Tumor protein 63 |
|||
V3816-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. [UniProt] |
|||
p63 Antibody / Tumor protein 63 |
|||
V3816SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. [UniProt] |
|||
p63 Antibody / Tumor protein 63 |
|||
V3947-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3947-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3947SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3948-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3948-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V3948SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V7466-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V7466-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V7466IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V7466SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9353-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9353-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9353SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9374-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9374-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9374SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9376-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9376-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
p63 Antibody / Tumor protein 63 |
|||
V9376SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
|||
Human Tumor Protein 63 (P63) ELISA Kit, 96 tests, Quantitative |
|||
9645 | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Tp63/ Rat Tp63 ELISA Kit |
|||
ELI-16159r | Lifescience Market | 96 Tests | 1063.2 EUR |
Human TP63 ELISA Kit |
|||
EHT0297 | Abclonal | 96Tests | 625.2 EUR |
TP63 ELISA KIT|Human |
|||
EF010885 | Lifescience Market | 96 Tests | 826.8 EUR |
Anti-p63 Antibody Clone TP63/1786, Unconjugated-20ug |
|||
8626-MSM6-P0 | EnQuireBio | 20ug | 279.6 EUR |
Anti-p63 Antibody Clone TP63/1786, Unconjugated-100ug |
|||
8626-MSM6-P1 | EnQuireBio | 100ug | 513.6 EUR |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC042427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405S conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC042427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405S conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC042428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405S conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC042428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405S conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCA2427-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), APC conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCA2428-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), APC conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCAP2427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCAP2427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCAP2428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCAP2428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCH2427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCH2427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCH2428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCH2428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCP2427-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), PerCP conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCP2428-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), PerCP conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC942427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF594 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC942427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF594 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC942428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF594 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC942428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF594 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC812427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC812427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC812428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC812428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCR2427-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), RPE conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCR2428-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), RPE conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/1786) Antibody |
|||
BNUB1786-50 | Biotium | 50uL | 486 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/1786), 1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCB2427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Biotin conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNCB2427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Biotin conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCB2428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Biotin conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNCB2428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Biotin conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC882427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF488A conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC882427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF488A conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC882428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF488A conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC882428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF488A conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC612427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF660R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC612427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF660R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC612428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF660R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC612428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF660R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC432427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF543 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC432427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF543 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC432428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF543 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC432428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF543 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC402427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF640R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC402427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF640R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC402428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF640R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC402428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF640R conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC552427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF555 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC552427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF555 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC552428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF555 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC552428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF555 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC802427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC802427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC802428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC802428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC052427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405M conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC052427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405M conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC052428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405M conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC052428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405M conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC702427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF770 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC702427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF770 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC702428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF770 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC702428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF770 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC472427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF647 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC472427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF647 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC472428-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF647 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|||
BNC472428-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF647 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC682427-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF568 conjugate, Concentration: 0.1mg/mL |
|||
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|||
BNC682427-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF568 conjugate, Concentration: 0.1mg/mL |
Human TP63(Tumor Protein P63) ELISA Kit